SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-003878
Filing Date
2019-02-13
Accepted
2019-02-13 19:52:26
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 doc1.html 5  
1 FORM 5 doc1.xml 5 3009
  Complete submission text file 0001567619-19-003878.txt   4358
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Issuer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Li Yvonne (Reporting) CIK: 0001735045 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35993 | Film No.: 19599963